Headaches and gluten: what science says

Il mal di testa e il glutine: cosa dice la scienza

Updated and contextualized version of an article originally published on June 25, 2014
The article retains its original focus by presenting it through a scholarly and accessible perspective, supported by verifiable references.


Authors

  • Dr. M. Mondini – Biologist
  • Roberto Panzironi –Independent researcher 

Note editoriali

  • First publication: June 25, 2014
  • Last update: April 20, 2026
  • Version: 2026 narrative revision  

Initial Note

This article is based on previously published content, updated according to scientific and informative criteria. The purpose is to inform the public about current studies and knowledge regarding the possible relationship between gluten and headache/migraine. The information provided here is for informational purposes only and does not replace medical advice: for clinical decisions or therapies, consult your doctor or a specialist.

In Brief

  • Some studies indicate an association between headache (including migraine) and gluten-related disorders, with symptom improvement in some patients following a gluten-free diet.
  • The literature includes clinical observations, epidemiological studies, and systematic reviews: methodological quality varies, and the causal relationship is not uniformly established.
  • Proposed mechanisms include immune processes (autoantibodies, inflammation), effects on the gut microbiota, and alterations of the blood-brain barrier; some autoimmune markers (e.g., anti-TG6) have been associated with neurological manifestations.
  • For individuals with suspected celiac disease or persistent neurological symptoms, guidelines recommend standard diagnostic evaluations; for the general population, indiscriminate adoption of a gluten-free diet is not recommended.

Abstract: What Does Science Say?

Definition: "gluten-headache relationship" here refers to the body of evidence linking gluten intake (or sensitivity to wheat components) to episodes or chronic forms of headache, including migraine. What the evidence shows: Clinical studies, case reports, and systematic reviews report a higher prevalence of headache in patients with celiac disease and, in some subgroups, an improvement in symptoms after a gluten-free diet. Many studies are observational or based on case series; few randomized controlled trials specifically address the relationship between gluten and headache. Plausible mechanisms: systemic immune reaction, autoimmunity against neural antigens (e.g., transglutaminase type 6), perivascular inflammation, and gut-brain axis interactions. Interpretive limitations: heterogeneity of studies, possible selection bias, nocebo/placebo effect in dietary studies, and confounding role of other wheat components (e.g., FODMAPs). In summary: a plausible association exists in some patients, but generalization and proof of causality require further controlled studies.

Main Section

Definition and Scope of the Problem

To understand the topic, it is useful to distinguish three clinical situations: celiac disease (an autoimmune condition diagnosable with serological markers and intestinal damage), wheat allergy (IgE-mediated mechanisms), and so-called non-celiac gluten sensitivity (NCGS), a more nuanced and still-defining entity. Neurological manifestations associated with gluten include ataxia, neuropathies, encephalopathy, and headache. Descriptive and observational studies have reported that headache is more frequent in patients diagnosed with celiac disease compared to the general population [1][2][3][4].

What the Main Evidence Shows

An original clinical work described the presence of brain abnormalities and headache in people with gluten sensitivity, with improvement after a gluten-free diet in many cases [1]. Broader reviews and meta-analyses have estimated a high prevalence of headache in the celiac disease population, suggesting a significant epidemiological link [2]. Large-scale cohort data indicate an increase in headache-related visits among patients with celiac disease compared to matched controls; this suggests a clinically relevant association but does not alone prove causality [3]. Additional case-control studies and clinical series support the possibility that, in a subset of patients, gluten removal reduces the frequency and intensity of attacks [4][8].

Dose, Frequency, and Context: What Influences the Effect

Evidence shows that the effect—when present—may depend on the underlying condition (celiac disease vs. non-celiac sensitivity), duration of exposure, and compliance with a gluten-free diet. Controlled studies on subjects with symptoms attributed to gluten highlight a problem: some improve even after placebo or react to other wheat components (e.g., FODMAPs), indicating that gluten is not always the direct cause of symptoms [5]. In subjects with documented celiac disease, a gluten-free diet remains the reference therapy and may be associated with a reduction in headache in some patients [2][3].

Practical Section

What It Means in Practice

For the general public: if you suffer from frequent headaches, it is not correct to automatically adopt a gluten-free diet without medical evaluation. The first rule is to rule out or confirm celiac disease with appropriate tests before starting a diet that can complicate diagnosis and follow-up. For those already diagnosed with celiac disease, there is evidence that dietary control can reduce neurological symptoms, including headache, in several cases [1][2][3].

When to Consider Further Diagnostic Investigations

It is reasonable to consult a doctor to evaluate: the presence of associated gastrointestinal symptoms, signs of malabsorption, family history of celiac disease or autoimmunity, and the presence of neurological abnormalities. In such contexts, serological tests and, if necessary, a specialist neurological or gastroenterological evaluation may be indicated. The approach should always be personalized and shared with healthcare professionals.

Key Takeaways

  • There is a documented association between celiac disease and a higher prevalence of headache/migraine, but the relationship is neither unique nor universal. [2][3]
  • In some patients with celiac disease or gluten sensitivity, adopting a gluten-free diet has been associated with an improvement in headache symptoms. [1][4]
  • Non-celiac gluten sensitivity is an evolving field; controlled studies have shown conflicting results, and other wheat components may explain symptoms in some cases. [5]
  • Proposed mechanisms include systemic immune response, neural autoantibodies, and gut-brain axis interactions; some biomarkers are under study (e.g., anti-TG6 antibodies). [6][7][8]

Limitations of Evidence

It is important to distinguish study types: much of the evidence is observational (cohorts, case series, case-control studies) which identify associations but do not establish causality. Controlled and randomized studies are few and, when present, sometimes show a placebo/nocebo effect or point to components other than gluten (e.g., FODMAPs). This makes it difficult to state that gluten is the direct cause of headache for most people. Furthermore, methodological heterogeneity, limited sample sizes, and possible selection and information biases reduce the strength of the conclusions. Caution is needed in interpretation, and well-designed controlled studies on target populations are required.

Editorial Conclusion

Research indicates that, for a portion of patients (particularly those with documented celiac disease), there is a connection between gluten intake and neurological disorders that may include headache. However, the relationship is not generalizable to the entire population and, for cases of non-celiac sensitivity, remains debated. Prudent clinical practice requires adequate diagnosis, exclusion of celiac disease before initiating a gluten-free diet, and multidisciplinary collaboration for the management of complex cases. New quality research is needed to clarify mechanisms, identify patients most likely to benefit from gluten exclusion, and provide recommendations based on robust evidence.

Editorial Note

This update was prepared with an institutional, balanced approach based on peer-reviewed literature. The article is intended to inform non-specialist readers while maintaining rigor and transparency in sources. For individual questions or therapeutic decisions, consultation with your trusted doctor is recommended.

SCIENTIFIC RESEARCH

  1. Hadjivassiliou M, Grünewald R, Chattopadhyay AK, et al. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology. 2001;56(3):385-388. https://doi.org/10.1212/WNL.56.3.385
  2. Zis P, Julian T, Hadjivassiliou M. Headache Associated with Coeliac Disease: A Systematic Review and Meta-Analysis. Nutrients. 2018;10(10):1445. https://doi.org/10.3390/nu10101445
  3. Lebwohl B, Roy A, Alaedini A, Green PH, Ludvigsson JF. Risk of Headache-Related Healthcare Visits in Patients with Celiac Disease: A Population-Based Observational Study. Headache. 2016;56(5):849-858. https://doi.org/10.1111/head.12784
  4. Dimitrova AK, Ungaro RC, Lebwohl B, et al. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache. 2013;53(2):344-355. https://doi.org/10.1111/j.1526-4610.2012.02260.x
  5. Biesiekierski JR, Newnham ED, Irving PM, et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Gastroenterology. 2013;145(2):320-328.e1-3. https://doi.org/10.1053/j.gastro.2013.04.051
  6. Jackson JR, Eaton WW, Cascella NG, Fasano A, Kelly DL. Neurologic and Psychiatric Manifestations of Celiac Disease and Gluten Sensitivity. Psychiatric Quarterly. 2012;83(1):91-102. https://doi.org/10.1007/s11126-011-9186-y
  7. Gillespie KM, et al. Autoantibodies in gluten ataxia recognize a novel neuronal transglutaminase. Ann Neurol. 2008;63:332-343. https://doi.org/10.1002/ana.21450
  8. Hadjivassiliou M, et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80(19):1740-1745. https://doi.org/10.1212/WNL.0b013e3182919070